data_2W06 # _entry.id 2W06 # _audit_conform.dict_name mmcif_pdbx.dic _audit_conform.dict_version 5.307 _audit_conform.dict_location http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic # loop_ _database_2.database_id _database_2.database_code PDB 2W06 PDBE EBI-37162 WWPDB D_1290037162 # loop_ _pdbx_database_related.db_name _pdbx_database_related.db_id _pdbx_database_related.content_type _pdbx_database_related.details PDB 1PYE unspecified 'CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR' PDB 1H08 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2VTH unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2B53 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325' PDB 1V1K unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 1OKV unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2' PDB 1KE7 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2- ONE ; PDB 1H25 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM E2F' PDB 1PXK unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE ; PDB 2BHH unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE' PDB 2VTA unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2UUE unspecified 'REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS' PDB 1GZ8 unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE ; PDB 1E1V unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058' PDB 1OL2 unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2' PDB 1H27 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27' PDB 1JSV unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4-[(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE' PDB 2B52 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562' PDB 1KE5 unspecified 'CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE' PDB 1FIN unspecified 'CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX' PDB 2C5O unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C68 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 2VTT unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1P2A unspecified 'THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR' PDB 2VTQ unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2C4G unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514' PDB 1W0X unspecified 'CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE.' PDB 1H1Q unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094' PDB 2W05 unspecified 'STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5B' PDB 1PXO unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2-AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)-AMINE ; PDB 1KE9 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- DIHYDRO-1H-INDOLE ; PDB 2A0C unspecified 'HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR' PDB 1HCK unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1JSU unspecified 'P27(KIP1)/CYCLIN A/CDK2 COMPLEX' PDB 1PXN unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4-METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL ; PDB 2UZE unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2VTM unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2V0D unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1OIQ unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 1H1R unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086' PDB 2IW8 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR' PDB 1GIH unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1HCL unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1PW2 unspecified 'APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 2VTN unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1JST unspecified 'PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A' PDB 1OIU unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 1PXM unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL' PDB 1B38 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1FQ1 unspecified 'CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX WITH PHOSPHO-CDK2' PDB 1VYW unspecified 'STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137' PDB 1H1P unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058' PDB 2C69 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1URC unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2' PDB 1PXI unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5-DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE' PDB 2C6I unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1YKR unspecified 'CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR' PDB 2UZD unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2C6K unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 2C5Y unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 1WCC unspecified 'SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY' PDB 2J9M unspecified 'CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE' PDB 1VYZ unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227' PDB 2VTI unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1JVP unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH PKF049-365' PDB 1W98 unspecified 'THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E' PDB 1PKD unspecified 'THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A' PDB 1P5E unspecified 'THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS)' PDB 2VTS unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2C5P unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2UZN unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2B54 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305' PDB 1KE6 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE ; PDB 1PXJ unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE' PDB 2UZL unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2CCI unspecified 'CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6' PDB 2BKZ unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611' PDB 2G9X unspecified 'STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/ CYCLIN A INCOMPLEX WITH THE INHIBITOR NU6271' PDB 1Y91 unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR' PDB 2IW6 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR' PDB 1GIJ unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1R78 unspecified 'CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR' PDB 1H0V unspecified ;HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE ; PDB 2IW9 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR' PDB 1W8C unspecified 'CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2' PDB 1BUH unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE-REGULATORY PROTEIN CKSHS1' PDB 2BPM unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529' PDB 2BTS unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032' PDB 1FVV unspecified 'THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR' PDB 1OKW unspecified 'CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2' PDB 2VTP unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2A4L unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE' PDB 2C6T unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1FVT unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN OXINDOLE INHIBITOR' PDB 1QMZ unspecified 'PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX' PDB 2VU3 unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1OGU unspecified ;STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR ; PDB 2B55 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE DIN-101312' PDB 1PF8 unspecified 'CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH A NUCLEOSIDE INHIBITOR' PDB 1H1S unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102' PDB 2C5V unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2JGZ unspecified 'CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B' PDB 2BHE unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO- INDIRUBINE' PDB 1URW unspecified 'CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE' PDB 1OIY unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 2C6L unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1F5Q unspecified 'CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDANT KINASE 2' PDB 2C6O unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 2VTL unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1OL1 unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2' PDB 1H01 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2UZB unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1OIR unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 1OI9 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 2VTJ unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2CJM unspecified 'MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE' PDB 2C5N unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C5X unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C6M unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1OIT unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 2V22 unspecified 'REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS' PDB 1GY3 unspecified 'PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE' PDB 2VV9 unspecified 'CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE' PDB 1GII unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1DI8 unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE' PDB 1E9H unspecified 'THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5- SULPHONATE BOUND' PDB 2VTO unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1DM2 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE' PDB 2UZO unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1H24 unspecified 'CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F' PDB 1H00 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2EXM unspecified 'HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE' PDB 2CLX unspecified ;4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS ; PDB 1PXP unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1,4-DIAMINE ; PDB 2CCH unspecified ;THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE ; PDB 1B39 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160' PDB 2BTR unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873' PDB 1AQ1 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE' PDB 1H0W unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE' PDB 1G5S unspecified 'CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN COMPLEX WITH THE INHIBITOR H717' PDB 1CKP unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B' PDB 1KE8 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL)BENZENESULFONAMIDE ; PDB 1H28 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107' PDB 1PXL unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)-AMINE ; PDB 2VTR unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1H26 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53' PDB 1E1X unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027' PDB 1H07 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 1Y8Y unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR' # _pdbx_database_status.status_code REL _pdbx_database_status.entry_id 2W06 _pdbx_database_status.deposit_site PDBE _pdbx_database_status.process_site PDBE _pdbx_database_status.SG_entry . _pdbx_database_status.recvd_initial_deposition_date 2008-08-08 _pdbx_database_status.pdb_format_compatible Y _pdbx_database_status.status_code_sf ? _pdbx_database_status.status_code_mr ? _pdbx_database_status.status_code_cs ? _pdbx_database_status.methods_development_category ? # loop_ _audit_author.name _audit_author.pdbx_ordinal 'Anderson, M.' 1 'Andrews, D.M.' 2 'Barker, A.J.' 3 'Brassington, C.A.' 4 'Byth, K.F.' 5 'Culshaw, J.D.' 6 'Finlay, M.R.V.' 7 'Fisher, E.' 8 'Mcmiken, H.H.J.' 9 'Green, C.P.' 10 'Heaton, D.W.' 11 'Nash, I.A.' 12 'Newcombe, N.J.' 13 'Oakes, S.E.' 14 'Roberts, A.' 15 'Stanway, J.J.' 16 'Thomas, A.P.' 17 'Tucker, J.A.' 18 'Weir, H.M.' 19 # _citation.id primary _citation.title 'Imidazoles: Sar and Development of a Potent Class of Cyclin-Dependent Kinase Inhibitors' _citation.journal_abbrev Bioorg.Med.Chem.Lett. _citation.journal_volume 18 _citation.page_first 5487 _citation.page_last ? _citation.year 2008 _citation.journal_id_ASTM BMCLE8 _citation.country UK _citation.journal_id_ISSN 0960-894X _citation.journal_id_CSD 1127 _citation.book_publisher ? _citation.pdbx_database_id_PubMed 18815031 _citation.pdbx_database_id_DOI 10.1016/J.BMCL.2008.09.024 # loop_ _citation_author.citation_id _citation_author.name _citation_author.ordinal _citation_author.identifier_ORCID primary 'Anderson, M.' 1 ? primary 'Andrews, D.M.' 2 ? primary 'Barker, A.J.' 3 ? primary 'Brassington, C.A.' 4 ? primary 'Breed, J.' 5 ? primary 'Byth, K.F.' 6 ? primary 'Culshaw, J.D.' 7 ? primary 'Finlay, M.R.V.' 8 ? primary 'Fisher, E.' 9 ? primary 'Mcmiken, H.H.J.' 10 ? primary 'Green, C.P.' 11 ? primary 'Heaton, D.W.' 12 ? primary 'Nash, I.A.' 13 ? primary 'Newcombe, N.J.' 14 ? primary 'Oakes, S.E.' 15 ? primary 'Pauptit, R.A.' 16 ? primary 'Roberts, A.' 17 ? primary 'Stanway, J.J.' 18 ? primary 'Thomas, A.P.' 19 ? primary 'Tucker, J.A.' 20 ? primary 'Walker, M.' 21 ? primary 'Weir, H.M.' 22 ? # _cell.entry_id 2W06 _cell.length_a 53.643 _cell.length_b 72.620 _cell.length_c 71.947 _cell.angle_alpha 90.00 _cell.angle_beta 90.00 _cell.angle_gamma 90.00 _cell.Z_PDB 4 _cell.pdbx_unique_axis ? # _symmetry.entry_id 2W06 _symmetry.space_group_name_H-M 'P 21 21 21' _symmetry.pdbx_full_space_group_name_H-M ? _symmetry.cell_setting ? _symmetry.Int_Tables_number 19 # loop_ _entity.id _entity.type _entity.src_method _entity.pdbx_description _entity.formula_weight _entity.pdbx_number_of_molecules _entity.pdbx_ec _entity.pdbx_mutation _entity.pdbx_fragment _entity.details 1 polymer man 'CELL DIVISION PROTEIN KINASE 2' 34002.527 1 2.7.11.22 ? ? ? 2 non-polymer syn '4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE' 384.455 1 ? ? ? ? 3 water nat water 18.015 140 ? ? ? ? # _entity_name_com.entity_id 1 _entity_name_com.name 'P33 PROTEIN KINASE, CDK2' # _entity_poly.entity_id 1 _entity_poly.type 'polypeptide(L)' _entity_poly.nstd_linkage no _entity_poly.nstd_monomer yes _entity_poly.pdbx_seq_one_letter_code ;(ACE)MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL ; _entity_poly.pdbx_seq_one_letter_code_can ;XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL ; _entity_poly.pdbx_strand_id A _entity_poly.pdbx_target_identifier ? # loop_ _entity_poly_seq.entity_id _entity_poly_seq.num _entity_poly_seq.mon_id _entity_poly_seq.hetero 1 1 ACE n 1 2 MET n 1 3 GLU n 1 4 ASN n 1 5 PHE n 1 6 GLN n 1 7 LYS n 1 8 VAL n 1 9 GLU n 1 10 LYS n 1 11 ILE n 1 12 GLY n 1 13 GLU n 1 14 GLY n 1 15 THR n 1 16 TYR n 1 17 GLY n 1 18 VAL n 1 19 VAL n 1 20 TYR n 1 21 LYS n 1 22 ALA n 1 23 ARG n 1 24 ASN n 1 25 LYS n 1 26 LEU n 1 27 THR n 1 28 GLY n 1 29 GLU n 1 30 VAL n 1 31 VAL n 1 32 ALA n 1 33 LEU n 1 34 LYS n 1 35 LYS n 1 36 ILE n 1 37 ARG n 1 38 LEU n 1 39 ASP n 1 40 THR n 1 41 GLU n 1 42 THR n 1 43 GLU n 1 44 GLY n 1 45 VAL n 1 46 PRO n 1 47 SER n 1 48 THR n 1 49 ALA n 1 50 ILE n 1 51 ARG n 1 52 GLU n 1 53 ILE n 1 54 SER n 1 55 LEU n 1 56 LEU n 1 57 LYS n 1 58 GLU n 1 59 LEU n 1 60 ASN n 1 61 HIS n 1 62 PRO n 1 63 ASN n 1 64 ILE n 1 65 VAL n 1 66 LYS n 1 67 LEU n 1 68 LEU n 1 69 ASP n 1 70 VAL n 1 71 ILE n 1 72 HIS n 1 73 THR n 1 74 GLU n 1 75 ASN n 1 76 LYS n 1 77 LEU n 1 78 TYR n 1 79 LEU n 1 80 VAL n 1 81 PHE n 1 82 GLU n 1 83 PHE n 1 84 LEU n 1 85 HIS n 1 86 GLN n 1 87 ASP n 1 88 LEU n 1 89 LYS n 1 90 LYS n 1 91 PHE n 1 92 MET n 1 93 ASP n 1 94 ALA n 1 95 SER n 1 96 ALA n 1 97 LEU n 1 98 THR n 1 99 GLY n 1 100 ILE n 1 101 PRO n 1 102 LEU n 1 103 PRO n 1 104 LEU n 1 105 ILE n 1 106 LYS n 1 107 SER n 1 108 TYR n 1 109 LEU n 1 110 PHE n 1 111 GLN n 1 112 LEU n 1 113 LEU n 1 114 GLN n 1 115 GLY n 1 116 LEU n 1 117 ALA n 1 118 PHE n 1 119 CYS n 1 120 HIS n 1 121 SER n 1 122 HIS n 1 123 ARG n 1 124 VAL n 1 125 LEU n 1 126 HIS n 1 127 ARG n 1 128 ASP n 1 129 LEU n 1 130 LYS n 1 131 PRO n 1 132 GLN n 1 133 ASN n 1 134 LEU n 1 135 LEU n 1 136 ILE n 1 137 ASN n 1 138 THR n 1 139 GLU n 1 140 GLY n 1 141 ALA n 1 142 ILE n 1 143 LYS n 1 144 LEU n 1 145 ALA n 1 146 ASP n 1 147 PHE n 1 148 GLY n 1 149 LEU n 1 150 ALA n 1 151 ARG n 1 152 ALA n 1 153 PHE n 1 154 GLY n 1 155 VAL n 1 156 PRO n 1 157 VAL n 1 158 ARG n 1 159 THR n 1 160 TYR n 1 161 THR n 1 162 HIS n 1 163 GLU n 1 164 VAL n 1 165 VAL n 1 166 THR n 1 167 LEU n 1 168 TRP n 1 169 TYR n 1 170 ARG n 1 171 ALA n 1 172 PRO n 1 173 GLU n 1 174 ILE n 1 175 LEU n 1 176 LEU n 1 177 GLY n 1 178 CYS n 1 179 LYS n 1 180 TYR n 1 181 TYR n 1 182 SER n 1 183 THR n 1 184 ALA n 1 185 VAL n 1 186 ASP n 1 187 ILE n 1 188 TRP n 1 189 SER n 1 190 LEU n 1 191 GLY n 1 192 CYS n 1 193 ILE n 1 194 PHE n 1 195 ALA n 1 196 GLU n 1 197 MET n 1 198 VAL n 1 199 THR n 1 200 ARG n 1 201 ARG n 1 202 ALA n 1 203 LEU n 1 204 PHE n 1 205 PRO n 1 206 GLY n 1 207 ASP n 1 208 SER n 1 209 GLU n 1 210 ILE n 1 211 ASP n 1 212 GLN n 1 213 LEU n 1 214 PHE n 1 215 ARG n 1 216 ILE n 1 217 PHE n 1 218 ARG n 1 219 THR n 1 220 LEU n 1 221 GLY n 1 222 THR n 1 223 PRO n 1 224 ASP n 1 225 GLU n 1 226 VAL n 1 227 VAL n 1 228 TRP n 1 229 PRO n 1 230 GLY n 1 231 VAL n 1 232 THR n 1 233 SER n 1 234 MET n 1 235 PRO n 1 236 ASP n 1 237 TYR n 1 238 LYS n 1 239 PRO n 1 240 SER n 1 241 PHE n 1 242 PRO n 1 243 LYS n 1 244 TRP n 1 245 ALA n 1 246 ARG n 1 247 GLN n 1 248 ASP n 1 249 PHE n 1 250 SER n 1 251 LYS n 1 252 VAL n 1 253 VAL n 1 254 PRO n 1 255 PRO n 1 256 LEU n 1 257 ASP n 1 258 GLU n 1 259 ASP n 1 260 GLY n 1 261 ARG n 1 262 SER n 1 263 LEU n 1 264 LEU n 1 265 SER n 1 266 GLN n 1 267 MET n 1 268 LEU n 1 269 HIS n 1 270 TYR n 1 271 ASP n 1 272 PRO n 1 273 ASN n 1 274 LYS n 1 275 ARG n 1 276 ILE n 1 277 SER n 1 278 ALA n 1 279 LYS n 1 280 ALA n 1 281 ALA n 1 282 LEU n 1 283 ALA n 1 284 HIS n 1 285 PRO n 1 286 PHE n 1 287 PHE n 1 288 GLN n 1 289 ASP n 1 290 VAL n 1 291 THR n 1 292 LYS n 1 293 PRO n 1 294 VAL n 1 295 PRO n 1 296 HIS n 1 297 LEU n 1 298 ARG n 1 299 LEU n # _entity_src_gen.entity_id 1 _entity_src_gen.pdbx_src_id 1 _entity_src_gen.pdbx_alt_source_flag sample _entity_src_gen.pdbx_seq_type ? _entity_src_gen.pdbx_beg_seq_num ? _entity_src_gen.pdbx_end_seq_num ? _entity_src_gen.gene_src_common_name HUMAN _entity_src_gen.gene_src_genus ? _entity_src_gen.pdbx_gene_src_gene ? _entity_src_gen.gene_src_species ? _entity_src_gen.gene_src_strain ? _entity_src_gen.gene_src_tissue ? _entity_src_gen.gene_src_tissue_fraction ? _entity_src_gen.gene_src_details ? _entity_src_gen.pdbx_gene_src_fragment ? _entity_src_gen.pdbx_gene_src_scientific_name 'HOMO SAPIENS' _entity_src_gen.pdbx_gene_src_ncbi_taxonomy_id 9606 _entity_src_gen.pdbx_gene_src_variant ? _entity_src_gen.pdbx_gene_src_cell_line ? _entity_src_gen.pdbx_gene_src_atcc ? _entity_src_gen.pdbx_gene_src_organ ? _entity_src_gen.pdbx_gene_src_organelle ? _entity_src_gen.pdbx_gene_src_cell ? _entity_src_gen.pdbx_gene_src_cellular_location ? _entity_src_gen.host_org_common_name ? _entity_src_gen.pdbx_host_org_scientific_name 'SPODOPTERA FRUGIPERDA' _entity_src_gen.pdbx_host_org_ncbi_taxonomy_id 7108 _entity_src_gen.host_org_genus ? _entity_src_gen.pdbx_host_org_gene ? _entity_src_gen.pdbx_host_org_organ ? _entity_src_gen.host_org_species ? _entity_src_gen.pdbx_host_org_tissue ? _entity_src_gen.pdbx_host_org_tissue_fraction ? _entity_src_gen.pdbx_host_org_strain ? _entity_src_gen.pdbx_host_org_variant ? _entity_src_gen.pdbx_host_org_cell_line Sf21 _entity_src_gen.pdbx_host_org_atcc ? _entity_src_gen.pdbx_host_org_culture_collection ? _entity_src_gen.pdbx_host_org_cell ? _entity_src_gen.pdbx_host_org_organelle ? _entity_src_gen.pdbx_host_org_cellular_location ? _entity_src_gen.pdbx_host_org_vector_type BACULOVIRUS _entity_src_gen.pdbx_host_org_vector ? _entity_src_gen.host_org_details ? _entity_src_gen.expression_system_id ? _entity_src_gen.plasmid_name ? _entity_src_gen.plasmid_details ? _entity_src_gen.pdbx_description ? # loop_ _struct_ref.id _struct_ref.db_name _struct_ref.db_code _struct_ref.entity_id _struct_ref.pdbx_seq_one_letter_code _struct_ref.pdbx_align_begin _struct_ref.pdbx_db_accession _struct_ref.pdbx_db_isoform 1 PDB 2W06 1 ? ? 2W06 ? 2 UNP CDK2_HUMAN 1 ? ? P24941 ? # loop_ _struct_ref_seq.align_id _struct_ref_seq.ref_id _struct_ref_seq.pdbx_PDB_id_code _struct_ref_seq.pdbx_strand_id _struct_ref_seq.seq_align_beg _struct_ref_seq.pdbx_seq_align_beg_ins_code _struct_ref_seq.seq_align_end _struct_ref_seq.pdbx_seq_align_end_ins_code _struct_ref_seq.pdbx_db_accession _struct_ref_seq.db_align_beg _struct_ref_seq.pdbx_db_align_beg_ins_code _struct_ref_seq.db_align_end _struct_ref_seq.pdbx_db_align_end_ins_code _struct_ref_seq.pdbx_auth_seq_align_beg _struct_ref_seq.pdbx_auth_seq_align_end 1 1 2W06 A 1 ? 1 ? 2W06 0 ? 0 ? 0 0 2 2 2W06 A 2 ? 299 ? P24941 1 ? 298 ? 1 298 # loop_ _chem_comp.id _chem_comp.type _chem_comp.mon_nstd_flag _chem_comp.name _chem_comp.pdbx_synonyms _chem_comp.formula _chem_comp.formula_weight ACE non-polymer . 'ACETYL GROUP' ? 'C2 H4 O' 44.053 ALA 'L-peptide linking' y ALANINE ? 'C3 H7 N O2' 89.093 ARG 'L-peptide linking' y ARGININE ? 'C6 H15 N4 O2 1' 175.209 ASN 'L-peptide linking' y ASPARAGINE ? 'C4 H8 N2 O3' 132.118 ASP 'L-peptide linking' y 'ASPARTIC ACID' ? 'C4 H7 N O4' 133.103 CYS 'L-peptide linking' y CYSTEINE ? 'C3 H7 N O2 S' 121.158 FRV non-polymer . '4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE' ? 'C18 H20 N6 O2 S' 384.455 GLN 'L-peptide linking' y GLUTAMINE ? 'C5 H10 N2 O3' 146.144 GLU 'L-peptide linking' y 'GLUTAMIC ACID' ? 'C5 H9 N O4' 147.129 GLY 'peptide linking' y GLYCINE ? 'C2 H5 N O2' 75.067 HIS 'L-peptide linking' y HISTIDINE ? 'C6 H10 N3 O2 1' 156.162 HOH non-polymer . WATER ? 'H2 O' 18.015 ILE 'L-peptide linking' y ISOLEUCINE ? 'C6 H13 N O2' 131.173 LEU 'L-peptide linking' y LEUCINE ? 'C6 H13 N O2' 131.173 LYS 'L-peptide linking' y LYSINE ? 'C6 H15 N2 O2 1' 147.195 MET 'L-peptide linking' y METHIONINE ? 'C5 H11 N O2 S' 149.211 PHE 'L-peptide linking' y PHENYLALANINE ? 'C9 H11 N O2' 165.189 PRO 'L-peptide linking' y PROLINE ? 'C5 H9 N O2' 115.130 SER 'L-peptide linking' y SERINE ? 'C3 H7 N O3' 105.093 THR 'L-peptide linking' y THREONINE ? 'C4 H9 N O3' 119.119 TRP 'L-peptide linking' y TRYPTOPHAN ? 'C11 H12 N2 O2' 204.225 TYR 'L-peptide linking' y TYROSINE ? 'C9 H11 N O3' 181.189 VAL 'L-peptide linking' y VALINE ? 'C5 H11 N O2' 117.146 # _exptl.entry_id 2W06 _exptl.method 'X-RAY DIFFRACTION' _exptl.crystals_number 1 # _exptl_crystal.id 1 _exptl_crystal.density_meas ? _exptl_crystal.density_Matthews 2.1 _exptl_crystal.density_percent_sol 41 _exptl_crystal.description NONE # _exptl_crystal_grow.crystal_id 1 _exptl_crystal_grow.method ? _exptl_crystal_grow.temp ? _exptl_crystal_grow.temp_details ? _exptl_crystal_grow.pH 7.4 _exptl_crystal_grow.pdbx_pH_range ? _exptl_crystal_grow.pdbx_details '8% PEG 3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE' # _diffrn.id 1 _diffrn.ambient_temp 100 _diffrn.ambient_temp_details ? _diffrn.crystal_id 1 # _diffrn_detector.diffrn_id 1 _diffrn_detector.detector 'IMAGE PLATE' _diffrn_detector.type MARRESEARCH _diffrn_detector.pdbx_collection_date 2001-12-12 _diffrn_detector.details 'OSMIC MIRRORS' # _diffrn_radiation.diffrn_id 1 _diffrn_radiation.wavelength_id 1 _diffrn_radiation.pdbx_monochromatic_or_laue_m_l M _diffrn_radiation.monochromator ? _diffrn_radiation.pdbx_diffrn_protocol 'SINGLE WAVELENGTH' _diffrn_radiation.pdbx_scattering_type x-ray # _diffrn_radiation_wavelength.id 1 _diffrn_radiation_wavelength.wavelength 1.54 _diffrn_radiation_wavelength.wt 1.0 # _diffrn_source.diffrn_id 1 _diffrn_source.source 'ROTATING ANODE' _diffrn_source.type 'ENRAF-NONIUS FR591' _diffrn_source.pdbx_synchrotron_site ? _diffrn_source.pdbx_synchrotron_beamline ? _diffrn_source.pdbx_wavelength 1.54 _diffrn_source.pdbx_wavelength_list ? # _reflns.pdbx_diffrn_id 1 _reflns.pdbx_ordinal 1 _reflns.entry_id 2W06 _reflns.observed_criterion_sigma_I 2.0 _reflns.observed_criterion_sigma_F ? _reflns.d_resolution_low 25.16 _reflns.d_resolution_high 2.05 _reflns.number_obs 17949 _reflns.number_all ? _reflns.percent_possible_obs 97.5 _reflns.pdbx_Rmerge_I_obs 0.05 _reflns.pdbx_Rsym_value ? _reflns.pdbx_netI_over_sigmaI 15.60 _reflns.B_iso_Wilson_estimate 27.2 _reflns.pdbx_redundancy 2.9 # _reflns_shell.pdbx_diffrn_id 1 _reflns_shell.pdbx_ordinal 1 _reflns_shell.d_res_high 2.04 _reflns_shell.d_res_low 2.15 _reflns_shell.percent_possible_all 91.7 _reflns_shell.Rmerge_I_obs 0.29 _reflns_shell.pdbx_Rsym_value ? _reflns_shell.meanI_over_sigI_obs 4.30 _reflns_shell.pdbx_redundancy 2.9 # _refine.pdbx_refine_id 'X-RAY DIFFRACTION' _refine.entry_id 2W06 _refine.pdbx_diffrn_id 1 _refine.pdbx_TLS_residual_ADP_flag ? _refine.ls_number_reflns_obs 17890 _refine.ls_number_reflns_all ? _refine.pdbx_ls_sigma_I ? _refine.pdbx_ls_sigma_F 0.0 _refine.pdbx_data_cutoff_high_absF ? _refine.pdbx_data_cutoff_low_absF ? _refine.pdbx_data_cutoff_high_rms_absF ? _refine.ls_d_res_low 200 _refine.ls_d_res_high 2.04 _refine.ls_percent_reflns_obs ? _refine.ls_R_factor_obs ? _refine.ls_R_factor_all ? _refine.ls_R_factor_R_work 0.2052 _refine.ls_R_factor_R_free 0.2337 _refine.ls_R_factor_R_free_error ? _refine.ls_R_factor_R_free_error_details ? _refine.ls_percent_reflns_R_free 4.7 _refine.ls_number_reflns_R_free 917 _refine.ls_number_parameters ? _refine.ls_number_restraints ? _refine.occupancy_min ? _refine.occupancy_max ? _refine.correlation_coeff_Fo_to_Fc ? _refine.correlation_coeff_Fo_to_Fc_free ? _refine.B_iso_mean 31.4 _refine.aniso_B[1][1] 3.337 _refine.aniso_B[2][2] -10.790 _refine.aniso_B[3][3] 7.453 _refine.aniso_B[1][2] 0.000 _refine.aniso_B[1][3] 0.000 _refine.aniso_B[2][3] 0.000 _refine.solvent_model_details MASK _refine.solvent_model_param_ksol ? _refine.solvent_model_param_bsol ? _refine.pdbx_solvent_vdw_probe_radii ? _refine.pdbx_solvent_ion_probe_radii ? _refine.pdbx_solvent_shrinkage_radii ? _refine.pdbx_ls_cross_valid_method THROUGHOUT _refine.details 'SIDE-CHAINS OF DISORDERED RESIDUES HAVE BEEN TRUNCATED TO ALANINE' _refine.pdbx_starting_model 'IN-HOUSE CDK2 STRUCTURE' _refine.pdbx_method_to_determine_struct 'MOLECULAR REPLACEMENT' _refine.pdbx_isotropic_thermal_model RESTRAINED _refine.pdbx_stereochemistry_target_values ? _refine.pdbx_stereochem_target_val_spec_case ? _refine.pdbx_R_Free_selection_details RANDOM _refine.pdbx_overall_ESU_R ? _refine.pdbx_overall_ESU_R_Free ? _refine.overall_SU_ML ? _refine.pdbx_overall_phase_error ? _refine.overall_SU_B ? _refine.overall_SU_R_Cruickshank_DPI ? _refine.pdbx_overall_SU_R_free_Cruickshank_DPI ? _refine.pdbx_overall_SU_R_Blow_DPI ? _refine.pdbx_overall_SU_R_free_Blow_DPI ? # _refine_hist.pdbx_refine_id 'X-RAY DIFFRACTION' _refine_hist.cycle_id LAST _refine_hist.pdbx_number_atoms_protein 2208 _refine_hist.pdbx_number_atoms_nucleic_acid 0 _refine_hist.pdbx_number_atoms_ligand 27 _refine_hist.number_atoms_solvent 140 _refine_hist.number_atoms_total 2375 _refine_hist.d_res_high 2.04 _refine_hist.d_res_low 200 # loop_ _refine_ls_restr.type _refine_ls_restr.dev_ideal _refine_ls_restr.dev_ideal_target _refine_ls_restr.weight _refine_ls_restr.number _refine_ls_restr.pdbx_refine_id _refine_ls_restr.pdbx_restraint_function c_bond_d 0.006177 ? ? ? 'X-RAY DIFFRACTION' ? c_bond_d_na ? ? ? ? 'X-RAY DIFFRACTION' ? c_bond_d_prot ? ? ? ? 'X-RAY DIFFRACTION' ? c_angle_d ? ? ? ? 'X-RAY DIFFRACTION' ? c_angle_d_na ? ? ? ? 'X-RAY DIFFRACTION' ? c_angle_d_prot ? ? ? ? 'X-RAY DIFFRACTION' ? c_angle_deg 1.30989 ? ? ? 'X-RAY DIFFRACTION' ? c_angle_deg_na ? ? ? ? 'X-RAY DIFFRACTION' ? c_angle_deg_prot ? ? ? ? 'X-RAY DIFFRACTION' ? c_dihedral_angle_d ? ? ? ? 'X-RAY DIFFRACTION' ? c_dihedral_angle_d_na ? ? ? ? 'X-RAY DIFFRACTION' ? c_dihedral_angle_d_prot ? ? ? ? 'X-RAY DIFFRACTION' ? c_improper_angle_d ? ? ? ? 'X-RAY DIFFRACTION' ? c_improper_angle_d_na ? ? ? ? 'X-RAY DIFFRACTION' ? c_improper_angle_d_prot ? ? ? ? 'X-RAY DIFFRACTION' ? c_mcbond_it 1.407 1.5 ? ? 'X-RAY DIFFRACTION' ? c_mcangle_it 2.031 2.0 ? ? 'X-RAY DIFFRACTION' ? c_scbond_it 2.170 2.0 ? ? 'X-RAY DIFFRACTION' ? c_scangle_it 2.868 2.5 ? ? 'X-RAY DIFFRACTION' ? # _refine_ls_shell.pdbx_refine_id 'X-RAY DIFFRACTION' _refine_ls_shell.pdbx_total_number_of_bins_used 18 _refine_ls_shell.d_res_high 2.04 _refine_ls_shell.d_res_low 2.08 _refine_ls_shell.number_reflns_R_work ? _refine_ls_shell.R_factor_R_work 0.3625 _refine_ls_shell.percent_reflns_obs ? _refine_ls_shell.R_factor_R_free 0.4148 _refine_ls_shell.R_factor_R_free_error ? _refine_ls_shell.percent_reflns_R_free 5.5 _refine_ls_shell.number_reflns_R_free ? _refine_ls_shell.number_reflns_all ? _refine_ls_shell.R_factor_all ? # _pdbx_xplor_file.pdbx_refine_id 'X-RAY DIFFRACTION' _pdbx_xplor_file.serial_no 1 _pdbx_xplor_file.param_file CPD5C.PAR _pdbx_xplor_file.topol_file CPD5C.TOP # _struct.entry_id 2W06 _struct.title 'Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5c' _struct.pdbx_descriptor 'CELL DIVISION PROTEIN KINASE 2 (E.C.2.7.11.22)' _struct.pdbx_model_details ? _struct.pdbx_CASP_flag ? _struct.pdbx_model_type_details ? # _struct_keywords.entry_id 2W06 _struct_keywords.pdbx_keywords TRANSFERASE _struct_keywords.text ;KINASE, MITOSIS, CELL CYCLE, TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, POLYMORPHISM, CELL DIVISION, PHOSPHOPROTEIN, PHOSPHORYLATION, NUCLEOTIDE-BINDING ; # loop_ _struct_asym.id _struct_asym.pdbx_blank_PDB_chainid_flag _struct_asym.pdbx_modified _struct_asym.entity_id _struct_asym.details A N N 1 ? B N N 2 ? C N N 3 ? # _struct_biol.id 1 # loop_ _struct_conf.conf_type_id _struct_conf.id _struct_conf.pdbx_PDB_helix_id _struct_conf.beg_label_comp_id _struct_conf.beg_label_asym_id _struct_conf.beg_label_seq_id _struct_conf.pdbx_beg_PDB_ins_code _struct_conf.end_label_comp_id _struct_conf.end_label_asym_id _struct_conf.end_label_seq_id _struct_conf.pdbx_end_PDB_ins_code _struct_conf.beg_auth_comp_id _struct_conf.beg_auth_asym_id _struct_conf.beg_auth_seq_id _struct_conf.end_auth_comp_id _struct_conf.end_auth_asym_id _struct_conf.end_auth_seq_id _struct_conf.pdbx_PDB_helix_class _struct_conf.details _struct_conf.pdbx_PDB_helix_length HELX_P HELX_P1 AA1 PRO A 46 ? LYS A 57 ? PRO A 45 LYS A 56 1 ? 12 HELX_P HELX_P2 AA2 LEU A 88 ? SER A 95 ? LEU A 87 SER A 94 1 ? 8 HELX_P HELX_P3 AA3 PRO A 101 ? HIS A 122 ? PRO A 100 HIS A 121 1 ? 22 HELX_P HELX_P4 AA4 LYS A 130 ? GLN A 132 ? LYS A 129 GLN A 131 5 ? 3 HELX_P HELX_P5 AA5 GLY A 148 ? PHE A 153 ? GLY A 147 PHE A 152 1 ? 6 HELX_P HELX_P6 AA6 ALA A 171 ? LEU A 176 ? ALA A 170 LEU A 175 1 ? 6 HELX_P HELX_P7 AA7 THR A 183 ? ARG A 200 ? THR A 182 ARG A 199 1 ? 18 HELX_P HELX_P8 AA8 SER A 208 ? GLY A 221 ? SER A 207 GLY A 220 1 ? 14 HELX_P HELX_P9 AA9 GLY A 230 ? MET A 234 ? GLY A 229 MET A 233 5 ? 5 HELX_P HELX_P10 AB1 ASP A 248 ? VAL A 253 ? ASP A 247 VAL A 252 1 ? 6 HELX_P HELX_P11 AB2 ASP A 257 ? LEU A 268 ? ASP A 256 LEU A 267 1 ? 12 HELX_P HELX_P12 AB3 SER A 277 ? ALA A 283 ? SER A 276 ALA A 282 1 ? 7 HELX_P HELX_P13 AB4 HIS A 284 ? GLN A 288 ? HIS A 283 GLN A 287 5 ? 5 # _struct_conf_type.id HELX_P _struct_conf_type.criteria ? _struct_conf_type.reference ? # _struct_conn.id covale1 _struct_conn.conn_type_id covale _struct_conn.pdbx_leaving_atom_flag both _struct_conn.pdbx_PDB_id ? _struct_conn.ptnr1_label_asym_id A _struct_conn.ptnr1_label_comp_id ACE _struct_conn.ptnr1_label_seq_id 1 _struct_conn.ptnr1_label_atom_id C _struct_conn.pdbx_ptnr1_label_alt_id ? _struct_conn.pdbx_ptnr1_PDB_ins_code ? _struct_conn.pdbx_ptnr1_standard_comp_id ? _struct_conn.ptnr1_symmetry 1_555 _struct_conn.ptnr2_label_asym_id A _struct_conn.ptnr2_label_comp_id MET _struct_conn.ptnr2_label_seq_id 2 _struct_conn.ptnr2_label_atom_id N _struct_conn.pdbx_ptnr2_label_alt_id ? _struct_conn.pdbx_ptnr2_PDB_ins_code ? _struct_conn.ptnr1_auth_asym_id A _struct_conn.ptnr1_auth_comp_id ACE _struct_conn.ptnr1_auth_seq_id 0 _struct_conn.ptnr2_auth_asym_id A _struct_conn.ptnr2_auth_comp_id MET _struct_conn.ptnr2_auth_seq_id 1 _struct_conn.ptnr2_symmetry 1_555 _struct_conn.pdbx_ptnr3_label_atom_id ? _struct_conn.pdbx_ptnr3_label_seq_id ? _struct_conn.pdbx_ptnr3_label_comp_id ? _struct_conn.pdbx_ptnr3_label_asym_id ? _struct_conn.pdbx_ptnr3_label_alt_id ? _struct_conn.pdbx_ptnr3_PDB_ins_code ? _struct_conn.details ? _struct_conn.pdbx_dist_value 1.331 _struct_conn.pdbx_value_order ? # _struct_conn_type.id covale _struct_conn_type.criteria ? _struct_conn_type.reference ? # loop_ _struct_sheet.id _struct_sheet.type _struct_sheet.number_strands _struct_sheet.details AA1 ? 5 ? AA2 ? 3 ? # loop_ _struct_sheet_order.sheet_id _struct_sheet_order.range_id_1 _struct_sheet_order.range_id_2 _struct_sheet_order.offset _struct_sheet_order.sense AA1 1 2 ? anti-parallel AA1 2 3 ? anti-parallel AA1 3 4 ? anti-parallel AA1 4 5 ? anti-parallel AA2 1 2 ? anti-parallel AA2 2 3 ? anti-parallel # loop_ _struct_sheet_range.sheet_id _struct_sheet_range.id _struct_sheet_range.beg_label_comp_id _struct_sheet_range.beg_label_asym_id _struct_sheet_range.beg_label_seq_id _struct_sheet_range.pdbx_beg_PDB_ins_code _struct_sheet_range.end_label_comp_id _struct_sheet_range.end_label_asym_id _struct_sheet_range.end_label_seq_id _struct_sheet_range.pdbx_end_PDB_ins_code _struct_sheet_range.beg_auth_comp_id _struct_sheet_range.beg_auth_asym_id _struct_sheet_range.beg_auth_seq_id _struct_sheet_range.end_auth_comp_id _struct_sheet_range.end_auth_asym_id _struct_sheet_range.end_auth_seq_id AA1 1 PHE A 5 ? GLU A 13 ? PHE A 4 GLU A 12 AA1 2 VAL A 18 ? ASN A 24 ? VAL A 17 ASN A 23 AA1 3 VAL A 30 ? ILE A 36 ? VAL A 29 ILE A 35 AA1 4 LYS A 76 ? GLU A 82 ? LYS A 75 GLU A 81 AA1 5 LEU A 67 ? THR A 73 ? LEU A 66 THR A 72 AA2 1 GLN A 86 ? ASP A 87 ? GLN A 85 ASP A 86 AA2 2 LEU A 134 ? ILE A 136 ? LEU A 133 ILE A 135 AA2 3 ILE A 142 ? LEU A 144 ? ILE A 141 LEU A 143 # loop_ _pdbx_struct_sheet_hbond.sheet_id _pdbx_struct_sheet_hbond.range_id_1 _pdbx_struct_sheet_hbond.range_id_2 _pdbx_struct_sheet_hbond.range_1_label_atom_id _pdbx_struct_sheet_hbond.range_1_label_comp_id _pdbx_struct_sheet_hbond.range_1_label_asym_id _pdbx_struct_sheet_hbond.range_1_label_seq_id _pdbx_struct_sheet_hbond.range_1_PDB_ins_code _pdbx_struct_sheet_hbond.range_1_auth_atom_id _pdbx_struct_sheet_hbond.range_1_auth_comp_id _pdbx_struct_sheet_hbond.range_1_auth_asym_id _pdbx_struct_sheet_hbond.range_1_auth_seq_id _pdbx_struct_sheet_hbond.range_2_label_atom_id _pdbx_struct_sheet_hbond.range_2_label_comp_id _pdbx_struct_sheet_hbond.range_2_label_asym_id _pdbx_struct_sheet_hbond.range_2_label_seq_id _pdbx_struct_sheet_hbond.range_2_PDB_ins_code _pdbx_struct_sheet_hbond.range_2_auth_atom_id _pdbx_struct_sheet_hbond.range_2_auth_comp_id _pdbx_struct_sheet_hbond.range_2_auth_asym_id _pdbx_struct_sheet_hbond.range_2_auth_seq_id AA1 1 2 N GLY A 12 ? N GLY A 11 O VAL A 19 ? O VAL A 18 AA1 2 3 N ALA A 22 ? N ALA A 21 O VAL A 31 ? O VAL A 30 AA1 3 4 N LYS A 34 ? N LYS A 33 O LEU A 79 ? O LEU A 78 AA1 4 5 O TYR A 78 ? O TYR A 77 N ILE A 71 ? N ILE A 70 AA2 1 2 N GLN A 86 ? N GLN A 85 O ILE A 136 ? O ILE A 135 AA2 2 3 N LEU A 135 ? N LEU A 134 O LYS A 143 ? O LYS A 142 # _struct_site.id AC1 _struct_site.pdbx_evidence_code Software _struct_site.pdbx_auth_asym_id A _struct_site.pdbx_auth_comp_id FRV _struct_site.pdbx_auth_seq_id 1300 _struct_site.pdbx_auth_ins_code ? _struct_site.pdbx_num_residues 12 _struct_site.details 'binding site for residue FRV A 1300' # loop_ _struct_site_gen.id _struct_site_gen.site_id _struct_site_gen.pdbx_num_res _struct_site_gen.label_comp_id _struct_site_gen.label_asym_id _struct_site_gen.label_seq_id _struct_site_gen.pdbx_auth_ins_code _struct_site_gen.auth_comp_id _struct_site_gen.auth_asym_id _struct_site_gen.auth_seq_id _struct_site_gen.label_atom_id _struct_site_gen.label_alt_id _struct_site_gen.symmetry _struct_site_gen.details 1 AC1 12 ILE A 11 ? ILE A 10 . ? 1_555 ? 2 AC1 12 ALA A 32 ? ALA A 31 . ? 1_555 ? 3 AC1 12 PHE A 81 ? PHE A 80 . ? 1_555 ? 4 AC1 12 GLU A 82 ? GLU A 81 . ? 1_555 ? 5 AC1 12 PHE A 83 ? PHE A 82 . ? 1_555 ? 6 AC1 12 LEU A 84 ? LEU A 83 . ? 1_555 ? 7 AC1 12 HIS A 85 ? HIS A 84 . ? 1_555 ? 8 AC1 12 GLN A 86 ? GLN A 85 . ? 1_555 ? 9 AC1 12 ASP A 87 ? ASP A 86 . ? 1_555 ? 10 AC1 12 LYS A 90 ? LYS A 89 . ? 1_555 ? 11 AC1 12 LEU A 135 ? LEU A 134 . ? 1_555 ? 12 AC1 12 ASP A 146 ? ASP A 145 . ? 1_555 ? # _database_PDB_matrix.entry_id 2W06 _database_PDB_matrix.origx[1][1] 1.000000 _database_PDB_matrix.origx[1][2] 0.000000 _database_PDB_matrix.origx[1][3] 0.000000 _database_PDB_matrix.origx[2][1] 0.000000 _database_PDB_matrix.origx[2][2] 1.000000 _database_PDB_matrix.origx[2][3] 0.000000 _database_PDB_matrix.origx[3][1] 0.000000 _database_PDB_matrix.origx[3][2] 0.000000 _database_PDB_matrix.origx[3][3] 1.000000 _database_PDB_matrix.origx_vector[1] 0.00000 _database_PDB_matrix.origx_vector[2] 0.00000 _database_PDB_matrix.origx_vector[3] 0.00000 # _atom_sites.entry_id 2W06 _atom_sites.fract_transf_matrix[1][1] 0.018642 _atom_sites.fract_transf_matrix[1][2] 0.000000 _atom_sites.fract_transf_matrix[1][3] 0.000000 _atom_sites.fract_transf_matrix[2][1] 0.000000 _atom_sites.fract_transf_matrix[2][2] 0.013770 _atom_sites.fract_transf_matrix[2][3] 0.000000 _atom_sites.fract_transf_matrix[3][1] 0.000000 _atom_sites.fract_transf_matrix[3][2] 0.000000 _atom_sites.fract_transf_matrix[3][3] 0.013899 _atom_sites.fract_transf_vector[1] 0.00000 _atom_sites.fract_transf_vector[2] 0.00000 _atom_sites.fract_transf_vector[3] 0.00000 # loop_ _atom_type.symbol C N O S # loop_ _pdbx_poly_seq_scheme.asym_id _pdbx_poly_seq_scheme.entity_id _pdbx_poly_seq_scheme.seq_id _pdbx_poly_seq_scheme.mon_id _pdbx_poly_seq_scheme.ndb_seq_num _pdbx_poly_seq_scheme.pdb_seq_num _pdbx_poly_seq_scheme.auth_seq_num _pdbx_poly_seq_scheme.pdb_mon_id _pdbx_poly_seq_scheme.auth_mon_id _pdbx_poly_seq_scheme.pdb_strand_id _pdbx_poly_seq_scheme.pdb_ins_code _pdbx_poly_seq_scheme.hetero A 1 1 ACE 1 0 0 ACE ACE A . n A 1 2 MET 2 1 1 MET MET A . n A 1 3 GLU 3 2 2 GLU GLU A . n A 1 4 ASN 4 3 3 ASN ASN A . n A 1 5 PHE 5 4 4 PHE PHE A . n A 1 6 GLN 6 5 5 GLN GLN A . n A 1 7 LYS 7 6 6 LYS LYS A . n A 1 8 VAL 8 7 7 VAL VAL A . n A 1 9 GLU 9 8 8 GLU GLU A . n A 1 10 LYS 10 9 9 LYS LYS A . n A 1 11 ILE 11 10 10 ILE ILE A . n A 1 12 GLY 12 11 11 GLY GLY A . n A 1 13 GLU 13 12 12 GLU GLU A . n A 1 14 GLY 14 13 13 GLY GLY A . n A 1 15 THR 15 14 14 THR THR A . n A 1 16 TYR 16 15 15 TYR TYR A . n A 1 17 GLY 17 16 16 GLY GLY A . n A 1 18 VAL 18 17 17 VAL VAL A . n A 1 19 VAL 19 18 18 VAL VAL A . n A 1 20 TYR 20 19 19 TYR TYR A . n A 1 21 LYS 21 20 20 LYS LYS A . n A 1 22 ALA 22 21 21 ALA ALA A . n A 1 23 ARG 23 22 22 ARG ARG A . n A 1 24 ASN 24 23 23 ASN ASN A . n A 1 25 LYS 25 24 24 LYS LYS A . n A 1 26 LEU 26 25 25 LEU LEU A . n A 1 27 THR 27 26 26 THR THR A . n A 1 28 GLY 28 27 27 GLY GLY A . n A 1 29 GLU 29 28 28 GLU GLU A . n A 1 30 VAL 30 29 29 VAL VAL A . n A 1 31 VAL 31 30 30 VAL VAL A . n A 1 32 ALA 32 31 31 ALA ALA A . n A 1 33 LEU 33 32 32 LEU LEU A . n A 1 34 LYS 34 33 33 LYS LYS A . n A 1 35 LYS 35 34 34 LYS LYS A . n A 1 36 ILE 36 35 35 ILE ILE A . n A 1 37 ARG 37 36 36 ARG ARG A . n A 1 38 LEU 38 37 ? ? ? A . n A 1 39 ASP 39 38 ? ? ? A . n A 1 40 THR 40 39 ? ? ? A . n A 1 41 GLU 41 40 ? ? ? A . n A 1 42 THR 42 41 ? ? ? A . n A 1 43 GLU 43 42 ? ? ? A . n A 1 44 GLY 44 43 ? ? ? A . n A 1 45 VAL 45 44 44 VAL VAL A . n A 1 46 PRO 46 45 45 PRO PRO A . n A 1 47 SER 47 46 46 SER SER A . n A 1 48 THR 48 47 47 THR THR A . n A 1 49 ALA 49 48 48 ALA ALA A . n A 1 50 ILE 50 49 49 ILE ILE A . n A 1 51 ARG 51 50 50 ARG ARG A . n A 1 52 GLU 52 51 51 GLU GLU A . n A 1 53 ILE 53 52 52 ILE ILE A . n A 1 54 SER 54 53 53 SER SER A . n A 1 55 LEU 55 54 54 LEU LEU A . n A 1 56 LEU 56 55 55 LEU LEU A . n A 1 57 LYS 57 56 56 LYS LYS A . n A 1 58 GLU 58 57 57 GLU GLU A . n A 1 59 LEU 59 58 58 LEU LEU A . n A 1 60 ASN 60 59 59 ASN ASN A . n A 1 61 HIS 61 60 60 HIS HIS A . n A 1 62 PRO 62 61 61 PRO PRO A . n A 1 63 ASN 63 62 62 ASN ASN A . n A 1 64 ILE 64 63 63 ILE ILE A . n A 1 65 VAL 65 64 64 VAL VAL A . n A 1 66 LYS 66 65 65 LYS LYS A . n A 1 67 LEU 67 66 66 LEU LEU A . n A 1 68 LEU 68 67 67 LEU LEU A . n A 1 69 ASP 69 68 68 ASP ASP A . n A 1 70 VAL 70 69 69 VAL VAL A . n A 1 71 ILE 71 70 70 ILE ILE A . n A 1 72 HIS 72 71 71 HIS HIS A . n A 1 73 THR 73 72 72 THR THR A . n A 1 74 GLU 74 73 73 GLU GLU A . n A 1 75 ASN 75 74 74 ASN ASN A . n A 1 76 LYS 76 75 75 LYS LYS A . n A 1 77 LEU 77 76 76 LEU LEU A . n A 1 78 TYR 78 77 77 TYR TYR A . n A 1 79 LEU 79 78 78 LEU LEU A . n A 1 80 VAL 80 79 79 VAL VAL A . n A 1 81 PHE 81 80 80 PHE PHE A . n A 1 82 GLU 82 81 81 GLU GLU A . n A 1 83 PHE 83 82 82 PHE PHE A . n A 1 84 LEU 84 83 83 LEU LEU A . n A 1 85 HIS 85 84 84 HIS HIS A . n A 1 86 GLN 86 85 85 GLN GLN A . n A 1 87 ASP 87 86 86 ASP ASP A . n A 1 88 LEU 88 87 87 LEU LEU A . n A 1 89 LYS 89 88 88 LYS LYS A . n A 1 90 LYS 90 89 89 LYS LYS A . n A 1 91 PHE 91 90 90 PHE PHE A . n A 1 92 MET 92 91 91 MET MET A . n A 1 93 ASP 93 92 92 ASP ASP A . n A 1 94 ALA 94 93 93 ALA ALA A . n A 1 95 SER 95 94 94 SER SER A . n A 1 96 ALA 96 95 95 ALA ALA A . n A 1 97 LEU 97 96 96 LEU LEU A . n A 1 98 THR 98 97 97 THR THR A . n A 1 99 GLY 99 98 98 GLY GLY A . n A 1 100 ILE 100 99 99 ILE ILE A . n A 1 101 PRO 101 100 100 PRO PRO A . n A 1 102 LEU 102 101 101 LEU LEU A . n A 1 103 PRO 103 102 102 PRO PRO A . n A 1 104 LEU 104 103 103 LEU LEU A . n A 1 105 ILE 105 104 104 ILE ILE A . n A 1 106 LYS 106 105 105 LYS LYS A . n A 1 107 SER 107 106 106 SER SER A . n A 1 108 TYR 108 107 107 TYR TYR A . n A 1 109 LEU 109 108 108 LEU LEU A . n A 1 110 PHE 110 109 109 PHE PHE A . n A 1 111 GLN 111 110 110 GLN GLN A . n A 1 112 LEU 112 111 111 LEU LEU A . n A 1 113 LEU 113 112 112 LEU LEU A . n A 1 114 GLN 114 113 113 GLN GLN A . n A 1 115 GLY 115 114 114 GLY GLY A . n A 1 116 LEU 116 115 115 LEU LEU A . n A 1 117 ALA 117 116 116 ALA ALA A . n A 1 118 PHE 118 117 117 PHE PHE A . n A 1 119 CYS 119 118 118 CYS CYS A . n A 1 120 HIS 120 119 119 HIS HIS A . n A 1 121 SER 121 120 120 SER SER A . n A 1 122 HIS 122 121 121 HIS HIS A . n A 1 123 ARG 123 122 122 ARG ARG A . n A 1 124 VAL 124 123 123 VAL VAL A . n A 1 125 LEU 125 124 124 LEU LEU A . n A 1 126 HIS 126 125 125 HIS HIS A . n A 1 127 ARG 127 126 126 ARG ARG A . n A 1 128 ASP 128 127 127 ASP ASP A . n A 1 129 LEU 129 128 128 LEU LEU A . n A 1 130 LYS 130 129 129 LYS LYS A . n A 1 131 PRO 131 130 130 PRO PRO A . n A 1 132 GLN 132 131 131 GLN GLN A . n A 1 133 ASN 133 132 132 ASN ASN A . n A 1 134 LEU 134 133 133 LEU LEU A . n A 1 135 LEU 135 134 134 LEU LEU A . n A 1 136 ILE 136 135 135 ILE ILE A . n A 1 137 ASN 137 136 136 ASN ASN A . n A 1 138 THR 138 137 137 THR THR A . n A 1 139 GLU 139 138 138 GLU GLU A . n A 1 140 GLY 140 139 139 GLY GLY A . n A 1 141 ALA 141 140 140 ALA ALA A . n A 1 142 ILE 142 141 141 ILE ILE A . n A 1 143 LYS 143 142 142 LYS LYS A . n A 1 144 LEU 144 143 143 LEU LEU A . n A 1 145 ALA 145 144 144 ALA ALA A . n A 1 146 ASP 146 145 145 ASP ASP A . n A 1 147 PHE 147 146 146 PHE PHE A . n A 1 148 GLY 148 147 147 GLY GLY A . n A 1 149 LEU 149 148 148 LEU LEU A . n A 1 150 ALA 150 149 149 ALA ALA A . n A 1 151 ARG 151 150 150 ARG ARG A . n A 1 152 ALA 152 151 151 ALA ALA A . n A 1 153 PHE 153 152 152 PHE PHE A . n A 1 154 GLY 154 153 ? ? ? A . n A 1 155 VAL 155 154 ? ? ? A . n A 1 156 PRO 156 155 ? ? ? A . n A 1 157 VAL 157 156 ? ? ? A . n A 1 158 ARG 158 157 ? ? ? A . n A 1 159 THR 159 158 ? ? ? A . n A 1 160 TYR 160 159 ? ? ? A . n A 1 161 THR 161 160 ? ? ? A . n A 1 162 HIS 162 161 ? ? ? A . n A 1 163 GLU 163 162 162 GLU GLU A . n A 1 164 VAL 164 163 163 VAL VAL A . n A 1 165 VAL 165 164 164 VAL VAL A . n A 1 166 THR 166 165 165 THR THR A . n A 1 167 LEU 167 166 166 LEU LEU A . n A 1 168 TRP 168 167 167 TRP TRP A . n A 1 169 TYR 169 168 168 TYR TYR A . n A 1 170 ARG 170 169 169 ARG ARG A . n A 1 171 ALA 171 170 170 ALA ALA A . n A 1 172 PRO 172 171 171 PRO PRO A . n A 1 173 GLU 173 172 172 GLU GLU A . n A 1 174 ILE 174 173 173 ILE ILE A . n A 1 175 LEU 175 174 174 LEU LEU A . n A 1 176 LEU 176 175 175 LEU LEU A . n A 1 177 GLY 177 176 176 GLY GLY A . n A 1 178 CYS 178 177 177 CYS CYS A . n A 1 179 LYS 179 178 178 LYS LYS A . n A 1 180 TYR 180 179 179 TYR TYR A . n A 1 181 TYR 181 180 180 TYR TYR A . n A 1 182 SER 182 181 181 SER SER A . n A 1 183 THR 183 182 182 THR THR A . n A 1 184 ALA 184 183 183 ALA ALA A . n A 1 185 VAL 185 184 184 VAL VAL A . n A 1 186 ASP 186 185 185 ASP ASP A . n A 1 187 ILE 187 186 186 ILE ILE A . n A 1 188 TRP 188 187 187 TRP TRP A . n A 1 189 SER 189 188 188 SER SER A . n A 1 190 LEU 190 189 189 LEU LEU A . n A 1 191 GLY 191 190 190 GLY GLY A . n A 1 192 CYS 192 191 191 CYS CYS A . n A 1 193 ILE 193 192 192 ILE ILE A . n A 1 194 PHE 194 193 193 PHE PHE A . n A 1 195 ALA 195 194 194 ALA ALA A . n A 1 196 GLU 196 195 195 GLU GLU A . n A 1 197 MET 197 196 196 MET MET A . n A 1 198 VAL 198 197 197 VAL VAL A . n A 1 199 THR 199 198 198 THR THR A . n A 1 200 ARG 200 199 199 ARG ARG A . n A 1 201 ARG 201 200 200 ARG ARG A . n A 1 202 ALA 202 201 201 ALA ALA A . n A 1 203 LEU 203 202 202 LEU LEU A . n A 1 204 PHE 204 203 203 PHE PHE A . n A 1 205 PRO 205 204 204 PRO PRO A . n A 1 206 GLY 206 205 205 GLY GLY A . n A 1 207 ASP 207 206 206 ASP ASP A . n A 1 208 SER 208 207 207 SER SER A . n A 1 209 GLU 209 208 208 GLU GLU A . n A 1 210 ILE 210 209 209 ILE ILE A . n A 1 211 ASP 211 210 210 ASP ASP A . n A 1 212 GLN 212 211 211 GLN GLN A . n A 1 213 LEU 213 212 212 LEU LEU A . n A 1 214 PHE 214 213 213 PHE PHE A . n A 1 215 ARG 215 214 214 ARG ARG A . n A 1 216 ILE 216 215 215 ILE ILE A . n A 1 217 PHE 217 216 216 PHE PHE A . n A 1 218 ARG 218 217 217 ARG ARG A . n A 1 219 THR 219 218 218 THR THR A . n A 1 220 LEU 220 219 219 LEU LEU A . n A 1 221 GLY 221 220 220 GLY GLY A . n A 1 222 THR 222 221 221 THR THR A . n A 1 223 PRO 223 222 222 PRO PRO A . n A 1 224 ASP 224 223 223 ASP ASP A . n A 1 225 GLU 225 224 224 GLU GLU A . n A 1 226 VAL 226 225 225 VAL VAL A . n A 1 227 VAL 227 226 226 VAL VAL A . n A 1 228 TRP 228 227 227 TRP TRP A . n A 1 229 PRO 229 228 228 PRO PRO A . n A 1 230 GLY 230 229 229 GLY GLY A . n A 1 231 VAL 231 230 230 VAL VAL A . n A 1 232 THR 232 231 231 THR THR A . n A 1 233 SER 233 232 232 SER SER A . n A 1 234 MET 234 233 233 MET MET A . n A 1 235 PRO 235 234 234 PRO PRO A . n A 1 236 ASP 236 235 235 ASP ASP A . n A 1 237 TYR 237 236 236 TYR TYR A . n A 1 238 LYS 238 237 237 LYS LYS A . n A 1 239 PRO 239 238 238 PRO PRO A . n A 1 240 SER 240 239 239 SER SER A . n A 1 241 PHE 241 240 240 PHE PHE A . n A 1 242 PRO 242 241 241 PRO PRO A . n A 1 243 LYS 243 242 242 LYS LYS A . n A 1 244 TRP 244 243 243 TRP TRP A . n A 1 245 ALA 245 244 244 ALA ALA A . n A 1 246 ARG 246 245 245 ARG ARG A . n A 1 247 GLN 247 246 246 GLN GLN A . n A 1 248 ASP 248 247 247 ASP ASP A . n A 1 249 PHE 249 248 248 PHE PHE A . n A 1 250 SER 250 249 249 SER SER A . n A 1 251 LYS 251 250 250 LYS LYS A . n A 1 252 VAL 252 251 251 VAL VAL A . n A 1 253 VAL 253 252 252 VAL VAL A . n A 1 254 PRO 254 253 253 PRO PRO A . n A 1 255 PRO 255 254 254 PRO PRO A . n A 1 256 LEU 256 255 255 LEU LEU A . n A 1 257 ASP 257 256 256 ASP ASP A . n A 1 258 GLU 258 257 257 GLU GLU A . n A 1 259 ASP 259 258 258 ASP ASP A . n A 1 260 GLY 260 259 259 GLY GLY A . n A 1 261 ARG 261 260 260 ARG ARG A . n A 1 262 SER 262 261 261 SER SER A . n A 1 263 LEU 263 262 262 LEU LEU A . n A 1 264 LEU 264 263 263 LEU LEU A . n A 1 265 SER 265 264 264 SER SER A . n A 1 266 GLN 266 265 265 GLN GLN A . n A 1 267 MET 267 266 266 MET MET A . n A 1 268 LEU 268 267 267 LEU LEU A . n A 1 269 HIS 269 268 268 HIS HIS A . n A 1 270 TYR 270 269 269 TYR TYR A . n A 1 271 ASP 271 270 270 ASP ASP A . n A 1 272 PRO 272 271 271 PRO PRO A . n A 1 273 ASN 273 272 272 ASN ASN A . n A 1 274 LYS 274 273 273 LYS LYS A . n A 1 275 ARG 275 274 274 ARG ARG A . n A 1 276 ILE 276 275 275 ILE ILE A . n A 1 277 SER 277 276 276 SER SER A . n A 1 278 ALA 278 277 277 ALA ALA A . n A 1 279 LYS 279 278 278 LYS LYS A . n A 1 280 ALA 280 279 279 ALA ALA A . n A 1 281 ALA 281 280 280 ALA ALA A . n A 1 282 LEU 282 281 281 LEU LEU A . n A 1 283 ALA 283 282 282 ALA ALA A . n A 1 284 HIS 284 283 283 HIS HIS A . n A 1 285 PRO 285 284 284 PRO PRO A . n A 1 286 PHE 286 285 285 PHE PHE A . n A 1 287 PHE 287 286 286 PHE PHE A . n A 1 288 GLN 288 287 287 GLN GLN A . n A 1 289 ASP 289 288 288 ASP ASP A . n A 1 290 VAL 290 289 289 VAL VAL A . n A 1 291 THR 291 290 290 THR THR A . n A 1 292 LYS 292 291 291 LYS LYS A . n A 1 293 PRO 293 292 292 PRO PRO A . n A 1 294 VAL 294 293 293 VAL VAL A . n A 1 295 PRO 295 294 294 PRO PRO A . n A 1 296 HIS 296 295 295 HIS HIS A . n A 1 297 LEU 297 296 296 LEU LEU A . n A 1 298 ARG 298 297 297 ARG ARG A . n A 1 299 LEU 299 298 298 LEU LEU A . n # loop_ _pdbx_nonpoly_scheme.asym_id _pdbx_nonpoly_scheme.entity_id _pdbx_nonpoly_scheme.mon_id _pdbx_nonpoly_scheme.ndb_seq_num _pdbx_nonpoly_scheme.pdb_seq_num _pdbx_nonpoly_scheme.auth_seq_num _pdbx_nonpoly_scheme.pdb_mon_id _pdbx_nonpoly_scheme.auth_mon_id _pdbx_nonpoly_scheme.pdb_strand_id _pdbx_nonpoly_scheme.pdb_ins_code B 2 FRV 1 1300 1300 FRV FRV A . C 3 HOH 1 1401 2112 HOH HOH A . C 3 HOH 2 1402 2048 HOH HOH A . C 3 HOH 3 1403 2102 HOH HOH A . C 3 HOH 4 1404 2006 HOH HOH A . C 3 HOH 5 1405 2103 HOH HOH A . C 3 HOH 6 1406 2043 HOH HOH A . C 3 HOH 7 1407 2129 HOH HOH A . C 3 HOH 8 1408 2087 HOH HOH A . C 3 HOH 9 1409 2111 HOH HOH A . C 3 HOH 10 1410 2052 HOH HOH A . C 3 HOH 11 1411 2105 HOH HOH A . C 3 HOH 12 1412 2110 HOH HOH A . C 3 HOH 13 1413 2137 HOH HOH A . C 3 HOH 14 1414 2074 HOH HOH A . C 3 HOH 15 1415 2080 HOH HOH A . C 3 HOH 16 1416 2100 HOH HOH A . C 3 HOH 17 1417 2084 HOH HOH A . C 3 HOH 18 1418 2115 HOH HOH A . C 3 HOH 19 1419 2134 HOH HOH A . C 3 HOH 20 1420 2081 HOH HOH A . C 3 HOH 21 1421 2060 HOH HOH A . C 3 HOH 22 1422 2004 HOH HOH A . C 3 HOH 23 1423 2058 HOH HOH A . C 3 HOH 24 1424 2131 HOH HOH A . C 3 HOH 25 1425 2051 HOH HOH A . C 3 HOH 26 1426 2091 HOH HOH A . C 3 HOH 27 1427 2090 HOH HOH A . C 3 HOH 28 1428 2138 HOH HOH A . C 3 HOH 29 1429 2033 HOH HOH A . C 3 HOH 30 1430 2030 HOH HOH A . C 3 HOH 31 1431 2085 HOH HOH A . C 3 HOH 32 1432 2116 HOH HOH A . C 3 HOH 33 1433 2055 HOH HOH A . C 3 HOH 34 1434 2038 HOH HOH A . C 3 HOH 35 1435 2079 HOH HOH A . C 3 HOH 36 1436 2008 HOH HOH A . C 3 HOH 37 1437 2095 HOH HOH A . C 3 HOH 38 1438 2059 HOH HOH A . C 3 HOH 39 1439 2026 HOH HOH A . C 3 HOH 40 1440 2044 HOH HOH A . C 3 HOH 41 1441 2139 HOH HOH A . C 3 HOH 42 1442 2056 HOH HOH A . C 3 HOH 43 1443 2120 HOH HOH A . C 3 HOH 44 1444 2077 HOH HOH A . C 3 HOH 45 1445 2068 HOH HOH A . C 3 HOH 46 1446 2013 HOH HOH A . C 3 HOH 47 1447 2053 HOH HOH A . C 3 HOH 48 1448 2106 HOH HOH A . C 3 HOH 49 1449 2050 HOH HOH A . C 3 HOH 50 1450 2061 HOH HOH A . C 3 HOH 51 1451 2054 HOH HOH A . C 3 HOH 52 1452 2122 HOH HOH A . C 3 HOH 53 1453 2066 HOH HOH A . C 3 HOH 54 1454 2069 HOH HOH A . C 3 HOH 55 1455 2124 HOH HOH A . C 3 HOH 56 1456 2132 HOH HOH A . C 3 HOH 57 1457 2117 HOH HOH A . C 3 HOH 58 1458 2072 HOH HOH A . C 3 HOH 59 1459 2130 HOH HOH A . C 3 HOH 60 1460 2086 HOH HOH A . C 3 HOH 61 1461 2027 HOH HOH A . C 3 HOH 62 1462 2020 HOH HOH A . C 3 HOH 63 1463 2096 HOH HOH A . C 3 HOH 64 1464 2075 HOH HOH A . C 3 HOH 65 1465 2040 HOH HOH A . C 3 HOH 66 1466 2007 HOH HOH A . C 3 HOH 67 1467 2042 HOH HOH A . C 3 HOH 68 1468 2062 HOH HOH A . C 3 HOH 69 1469 2067 HOH HOH A . C 3 HOH 70 1470 2021 HOH HOH A . C 3 HOH 71 1471 2099 HOH HOH A . C 3 HOH 72 1472 2128 HOH HOH A . C 3 HOH 73 1473 2034 HOH HOH A . C 3 HOH 74 1474 2107 HOH HOH A . C 3 HOH 75 1475 2093 HOH HOH A . C 3 HOH 76 1476 2076 HOH HOH A . C 3 HOH 77 1477 2032 HOH HOH A . C 3 HOH 78 1478 2078 HOH HOH A . C 3 HOH 79 1479 2016 HOH HOH A . C 3 HOH 80 1480 2031 HOH HOH A . C 3 HOH 81 1481 2022 HOH HOH A . C 3 HOH 82 1482 2126 HOH HOH A . C 3 HOH 83 1483 2014 HOH HOH A . C 3 HOH 84 1484 2083 HOH HOH A . C 3 HOH 85 1485 2037 HOH HOH A . C 3 HOH 86 1486 2101 HOH HOH A . C 3 HOH 87 1487 2098 HOH HOH A . C 3 HOH 88 1488 2073 HOH HOH A . C 3 HOH 89 1489 2005 HOH HOH A . C 3 HOH 90 1490 2017 HOH HOH A . C 3 HOH 91 1491 2028 HOH HOH A . C 3 HOH 92 1492 2113 HOH HOH A . C 3 HOH 93 1493 2019 HOH HOH A . C 3 HOH 94 1494 2049 HOH HOH A . C 3 HOH 95 1495 2057 HOH HOH A . C 3 HOH 96 1496 2140 HOH HOH A . C 3 HOH 97 1497 2070 HOH HOH A . C 3 HOH 98 1498 2104 HOH HOH A . C 3 HOH 99 1499 2123 HOH HOH A . C 3 HOH 100 1500 2118 HOH HOH A . C 3 HOH 101 1501 2088 HOH HOH A . C 3 HOH 102 1502 2125 HOH HOH A . C 3 HOH 103 1503 2135 HOH HOH A . C 3 HOH 104 1504 2041 HOH HOH A . C 3 HOH 105 1505 2071 HOH HOH A . C 3 HOH 106 1506 2092 HOH HOH A . C 3 HOH 107 1507 2063 HOH HOH A . C 3 HOH 108 1508 2108 HOH HOH A . C 3 HOH 109 1509 2136 HOH HOH A . C 3 HOH 110 1510 2065 HOH HOH A . C 3 HOH 111 1511 2094 HOH HOH A . C 3 HOH 112 1512 2127 HOH HOH A . C 3 HOH 113 1513 2121 HOH HOH A . C 3 HOH 114 1514 2133 HOH HOH A . C 3 HOH 115 1515 2015 HOH HOH A . C 3 HOH 116 1516 2114 HOH HOH A . C 3 HOH 117 1517 2097 HOH HOH A . C 3 HOH 118 1518 2119 HOH HOH A . C 3 HOH 119 1519 2018 HOH HOH A . C 3 HOH 120 1520 2064 HOH HOH A . C 3 HOH 121 1521 2046 HOH HOH A . C 3 HOH 122 1522 2109 HOH HOH A . C 3 HOH 123 1523 2010 HOH HOH A . C 3 HOH 124 1524 2036 HOH HOH A . C 3 HOH 125 1525 2002 HOH HOH A . C 3 HOH 126 1526 2045 HOH HOH A . C 3 HOH 127 1527 2047 HOH HOH A . C 3 HOH 128 1528 2082 HOH HOH A . C 3 HOH 129 1529 2024 HOH HOH A . C 3 HOH 130 1530 2025 HOH HOH A . C 3 HOH 131 1531 2011 HOH HOH A . C 3 HOH 132 1532 2089 HOH HOH A . C 3 HOH 133 1533 2001 HOH HOH A . C 3 HOH 134 1534 2029 HOH HOH A . C 3 HOH 135 1535 2009 HOH HOH A . C 3 HOH 136 1536 2012 HOH HOH A . C 3 HOH 137 1537 2035 HOH HOH A . C 3 HOH 138 1538 2023 HOH HOH A . C 3 HOH 139 1539 2003 HOH HOH A . C 3 HOH 140 1540 2039 HOH HOH A . # _pdbx_struct_assembly.id 1 _pdbx_struct_assembly.details author_and_software_defined_assembly _pdbx_struct_assembly.method_details PQS _pdbx_struct_assembly.oligomeric_details monomeric _pdbx_struct_assembly.oligomeric_count 1 # _pdbx_struct_assembly_gen.assembly_id 1 _pdbx_struct_assembly_gen.oper_expression 1 _pdbx_struct_assembly_gen.asym_id_list A,B,C # _pdbx_struct_oper_list.id 1 _pdbx_struct_oper_list.type 'identity operation' _pdbx_struct_oper_list.name 1_555 _pdbx_struct_oper_list.symmetry_operation x,y,z _pdbx_struct_oper_list.matrix[1][1] 1.0000000000 _pdbx_struct_oper_list.matrix[1][2] 0.0000000000 _pdbx_struct_oper_list.matrix[1][3] 0.0000000000 _pdbx_struct_oper_list.vector[1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][2] 1.0000000000 _pdbx_struct_oper_list.matrix[2][3] 0.0000000000 _pdbx_struct_oper_list.vector[2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][1] 0.0000000000 _pdbx_struct_oper_list.matrix[3][2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][3] 1.0000000000 _pdbx_struct_oper_list.vector[3] 0.0000000000 # loop_ _pdbx_audit_revision_history.ordinal _pdbx_audit_revision_history.data_content_type _pdbx_audit_revision_history.major_revision _pdbx_audit_revision_history.minor_revision _pdbx_audit_revision_history.revision_date 1 'Structure model' 1 0 2008-09-23 2 'Structure model' 1 1 2011-05-07 3 'Structure model' 1 2 2011-07-13 4 'Structure model' 2 0 2017-07-05 5 'Structure model' 2 1 2019-04-24 # _pdbx_audit_revision_details.ordinal 1 _pdbx_audit_revision_details.revision_ordinal 1 _pdbx_audit_revision_details.data_content_type 'Structure model' _pdbx_audit_revision_details.provider repository _pdbx_audit_revision_details.type 'Initial release' _pdbx_audit_revision_details.description ? # loop_ _pdbx_audit_revision_group.ordinal _pdbx_audit_revision_group.revision_ordinal _pdbx_audit_revision_group.data_content_type _pdbx_audit_revision_group.group 1 2 'Structure model' 'Version format compliance' 2 3 'Structure model' 'Version format compliance' 3 4 'Structure model' 'Atomic model' 4 4 'Structure model' 'Data collection' 5 4 'Structure model' 'Derived calculations' 6 5 'Structure model' 'Data collection' 7 5 'Structure model' 'Source and taxonomy' # loop_ _pdbx_audit_revision_category.ordinal _pdbx_audit_revision_category.revision_ordinal _pdbx_audit_revision_category.data_content_type _pdbx_audit_revision_category.category 1 4 'Structure model' atom_site 2 4 'Structure model' diffrn_source 3 4 'Structure model' pdbx_struct_sheet_hbond 4 4 'Structure model' struct_conf 5 4 'Structure model' struct_conn 6 4 'Structure model' struct_sheet 7 4 'Structure model' struct_sheet_order 8 4 'Structure model' struct_sheet_range 9 4 'Structure model' struct_site 10 5 'Structure model' entity_src_gen # loop_ _pdbx_audit_revision_item.ordinal _pdbx_audit_revision_item.revision_ordinal _pdbx_audit_revision_item.data_content_type _pdbx_audit_revision_item.item 1 4 'Structure model' '_atom_site.B_iso_or_equiv' 2 4 'Structure model' '_atom_site.Cartn_x' 3 4 'Structure model' '_atom_site.Cartn_y' 4 4 'Structure model' '_atom_site.Cartn_z' 5 4 'Structure model' '_atom_site.auth_seq_id' 6 4 'Structure model' '_diffrn_source.type' 7 4 'Structure model' '_pdbx_struct_sheet_hbond.range_1_auth_comp_id' 8 4 'Structure model' '_pdbx_struct_sheet_hbond.range_1_auth_seq_id' 9 4 'Structure model' '_pdbx_struct_sheet_hbond.range_1_label_comp_id' 10 4 'Structure model' '_pdbx_struct_sheet_hbond.range_1_label_seq_id' 11 4 'Structure model' '_pdbx_struct_sheet_hbond.range_2_auth_comp_id' 12 4 'Structure model' '_pdbx_struct_sheet_hbond.range_2_auth_seq_id' 13 4 'Structure model' '_pdbx_struct_sheet_hbond.range_2_label_comp_id' 14 4 'Structure model' '_pdbx_struct_sheet_hbond.range_2_label_seq_id' 15 4 'Structure model' '_pdbx_struct_sheet_hbond.sheet_id' 16 4 'Structure model' '_struct_conf.pdbx_PDB_helix_id' 17 4 'Structure model' '_struct_conn.pdbx_leaving_atom_flag' 18 4 'Structure model' '_struct_sheet.id' 19 4 'Structure model' '_struct_sheet_order.sheet_id' 20 4 'Structure model' '_struct_sheet_range.sheet_id' 21 4 'Structure model' '_struct_site.details' 22 4 'Structure model' '_struct_site.pdbx_auth_asym_id' 23 4 'Structure model' '_struct_site.pdbx_auth_comp_id' 24 4 'Structure model' '_struct_site.pdbx_auth_seq_id' 25 5 'Structure model' '_entity_src_gen.pdbx_host_org_cell_line' # loop_ _software.name _software.classification _software.version _software.citation_id _software.pdbx_ordinal CNX refinement 2000 ? 1 MOSFLM 'data reduction' . ? 2 SCALA 'data scaling' . ? 3 AMoRE phasing . ? 4 # _pdbx_entry_details.entry_id 2W06 _pdbx_entry_details.compound_details ? _pdbx_entry_details.source_details ? _pdbx_entry_details.nonpolymer_details 'ACETYL (ACE): N-TERMINUS IS ACETYLATED' _pdbx_entry_details.sequence_details ;RESIDUES WITH DISORDERED SIDE-CHAINS HAVE BEEN MODELLED AS ALANINE. ; # _pdbx_validate_rmsd_angle.id 1 _pdbx_validate_rmsd_angle.PDB_model_num 1 _pdbx_validate_rmsd_angle.auth_atom_id_1 C _pdbx_validate_rmsd_angle.auth_asym_id_1 A _pdbx_validate_rmsd_angle.auth_comp_id_1 VAL _pdbx_validate_rmsd_angle.auth_seq_id_1 252 _pdbx_validate_rmsd_angle.PDB_ins_code_1 ? _pdbx_validate_rmsd_angle.label_alt_id_1 ? _pdbx_validate_rmsd_angle.auth_atom_id_2 N _pdbx_validate_rmsd_angle.auth_asym_id_2 A _pdbx_validate_rmsd_angle.auth_comp_id_2 PRO _pdbx_validate_rmsd_angle.auth_seq_id_2 253 _pdbx_validate_rmsd_angle.PDB_ins_code_2 ? _pdbx_validate_rmsd_angle.label_alt_id_2 ? _pdbx_validate_rmsd_angle.auth_atom_id_3 CA _pdbx_validate_rmsd_angle.auth_asym_id_3 A _pdbx_validate_rmsd_angle.auth_comp_id_3 PRO _pdbx_validate_rmsd_angle.auth_seq_id_3 253 _pdbx_validate_rmsd_angle.PDB_ins_code_3 ? _pdbx_validate_rmsd_angle.label_alt_id_3 ? _pdbx_validate_rmsd_angle.angle_value 128.32 _pdbx_validate_rmsd_angle.angle_target_value 119.30 _pdbx_validate_rmsd_angle.angle_deviation 9.02 _pdbx_validate_rmsd_angle.angle_standard_deviation 1.50 _pdbx_validate_rmsd_angle.linker_flag Y # loop_ _pdbx_validate_torsion.id _pdbx_validate_torsion.PDB_model_num _pdbx_validate_torsion.auth_comp_id _pdbx_validate_torsion.auth_asym_id _pdbx_validate_torsion.auth_seq_id _pdbx_validate_torsion.PDB_ins_code _pdbx_validate_torsion.label_alt_id _pdbx_validate_torsion.phi _pdbx_validate_torsion.psi 1 1 LEU A 25 ? ? -95.79 -60.45 2 1 ARG A 126 ? ? 84.99 -24.63 3 1 TYR A 179 ? ? -112.46 61.29 4 1 PRO A 253 ? ? -18.32 -68.15 # loop_ _pdbx_unobs_or_zero_occ_atoms.id _pdbx_unobs_or_zero_occ_atoms.PDB_model_num _pdbx_unobs_or_zero_occ_atoms.polymer_flag _pdbx_unobs_or_zero_occ_atoms.occupancy_flag _pdbx_unobs_or_zero_occ_atoms.auth_asym_id _pdbx_unobs_or_zero_occ_atoms.auth_comp_id _pdbx_unobs_or_zero_occ_atoms.auth_seq_id _pdbx_unobs_or_zero_occ_atoms.PDB_ins_code _pdbx_unobs_or_zero_occ_atoms.auth_atom_id _pdbx_unobs_or_zero_occ_atoms.label_alt_id _pdbx_unobs_or_zero_occ_atoms.label_asym_id _pdbx_unobs_or_zero_occ_atoms.label_comp_id _pdbx_unobs_or_zero_occ_atoms.label_seq_id _pdbx_unobs_or_zero_occ_atoms.label_atom_id 1 1 Y 1 A LYS 6 ? CG ? A LYS 7 CG 2 1 Y 1 A LYS 6 ? CD ? A LYS 7 CD 3 1 Y 1 A LYS 6 ? CE ? A LYS 7 CE 4 1 Y 1 A LYS 6 ? NZ ? A LYS 7 NZ 5 1 Y 1 A GLU 12 ? CG ? A GLU 13 CG 6 1 Y 1 A GLU 12 ? CD ? A GLU 13 CD 7 1 Y 1 A GLU 12 ? OE1 ? A GLU 13 OE1 8 1 Y 1 A GLU 12 ? OE2 ? A GLU 13 OE2 9 1 Y 1 A LEU 25 ? CG ? A LEU 26 CG 10 1 Y 1 A LEU 25 ? CD1 ? A LEU 26 CD1 11 1 Y 1 A LEU 25 ? CD2 ? A LEU 26 CD2 12 1 Y 1 A ARG 36 ? CG ? A ARG 37 CG 13 1 Y 1 A ARG 36 ? CD ? A ARG 37 CD 14 1 Y 1 A ARG 36 ? NE ? A ARG 37 NE 15 1 Y 1 A ARG 36 ? CZ ? A ARG 37 CZ 16 1 Y 1 A ARG 36 ? NH1 ? A ARG 37 NH1 17 1 Y 1 A ARG 36 ? NH2 ? A ARG 37 NH2 18 1 Y 1 A ARG 50 ? CG ? A ARG 51 CG 19 1 Y 1 A ARG 50 ? CD ? A ARG 51 CD 20 1 Y 1 A ARG 50 ? NE ? A ARG 51 NE 21 1 Y 1 A ARG 50 ? CZ ? A ARG 51 CZ 22 1 Y 1 A ARG 50 ? NH1 ? A ARG 51 NH1 23 1 Y 1 A ARG 50 ? NH2 ? A ARG 51 NH2 24 1 Y 1 A GLU 51 ? CG ? A GLU 52 CG 25 1 Y 1 A GLU 51 ? CD ? A GLU 52 CD 26 1 Y 1 A GLU 51 ? OE1 ? A GLU 52 OE1 27 1 Y 1 A GLU 51 ? OE2 ? A GLU 52 OE2 28 1 Y 1 A LYS 56 ? CG ? A LYS 57 CG 29 1 Y 1 A LYS 56 ? CD ? A LYS 57 CD 30 1 Y 1 A LYS 56 ? CE ? A LYS 57 CE 31 1 Y 1 A LYS 56 ? NZ ? A LYS 57 NZ 32 1 Y 1 A ASN 74 ? CG ? A ASN 75 CG 33 1 Y 1 A ASN 74 ? OD1 ? A ASN 75 OD1 34 1 Y 1 A ASN 74 ? ND2 ? A ASN 75 ND2 35 1 Y 1 A LYS 75 ? CG ? A LYS 76 CG 36 1 Y 1 A LYS 75 ? CD ? A LYS 76 CD 37 1 Y 1 A LYS 75 ? CE ? A LYS 76 CE 38 1 Y 1 A LYS 75 ? NZ ? A LYS 76 NZ 39 1 Y 1 A LEU 96 ? CG ? A LEU 97 CG 40 1 Y 1 A LEU 96 ? CD1 ? A LEU 97 CD1 41 1 Y 1 A LEU 96 ? CD2 ? A LEU 97 CD2 42 1 Y 1 A ARG 126 ? CG ? A ARG 127 CG 43 1 Y 1 A ARG 126 ? CD ? A ARG 127 CD 44 1 Y 1 A ARG 126 ? NE ? A ARG 127 NE 45 1 Y 1 A ARG 126 ? CZ ? A ARG 127 CZ 46 1 Y 1 A ARG 126 ? NH1 ? A ARG 127 NH1 47 1 Y 1 A ARG 126 ? NH2 ? A ARG 127 NH2 48 1 Y 1 A GLU 162 ? CG ? A GLU 163 CG 49 1 Y 1 A GLU 162 ? CD ? A GLU 163 CD 50 1 Y 1 A GLU 162 ? OE1 ? A GLU 163 OE1 51 1 Y 1 A GLU 162 ? OE2 ? A GLU 163 OE2 52 1 Y 1 A VAL 163 ? CG1 ? A VAL 164 CG1 53 1 Y 1 A VAL 163 ? CG2 ? A VAL 164 CG2 54 1 Y 1 A VAL 164 ? CG1 ? A VAL 165 CG1 55 1 Y 1 A VAL 164 ? CG2 ? A VAL 165 CG2 56 1 Y 1 A LYS 178 ? CG ? A LYS 179 CG 57 1 Y 1 A LYS 178 ? CD ? A LYS 179 CD 58 1 Y 1 A LYS 178 ? CE ? A LYS 179 CE 59 1 Y 1 A LYS 178 ? NZ ? A LYS 179 NZ 60 1 Y 1 A LYS 278 ? CG ? A LYS 279 CG 61 1 Y 1 A LYS 278 ? CD ? A LYS 279 CD 62 1 Y 1 A LYS 278 ? CE ? A LYS 279 CE 63 1 Y 1 A LYS 278 ? NZ ? A LYS 279 NZ 64 1 Y 1 A ARG 297 ? CG ? A ARG 298 CG 65 1 Y 1 A ARG 297 ? CD ? A ARG 298 CD 66 1 Y 1 A ARG 297 ? NE ? A ARG 298 NE 67 1 Y 1 A ARG 297 ? CZ ? A ARG 298 CZ 68 1 Y 1 A ARG 297 ? NH1 ? A ARG 298 NH1 69 1 Y 1 A ARG 297 ? NH2 ? A ARG 298 NH2 # loop_ _pdbx_unobs_or_zero_occ_residues.id _pdbx_unobs_or_zero_occ_residues.PDB_model_num _pdbx_unobs_or_zero_occ_residues.polymer_flag _pdbx_unobs_or_zero_occ_residues.occupancy_flag _pdbx_unobs_or_zero_occ_residues.auth_asym_id _pdbx_unobs_or_zero_occ_residues.auth_comp_id _pdbx_unobs_or_zero_occ_residues.auth_seq_id _pdbx_unobs_or_zero_occ_residues.PDB_ins_code _pdbx_unobs_or_zero_occ_residues.label_asym_id _pdbx_unobs_or_zero_occ_residues.label_comp_id _pdbx_unobs_or_zero_occ_residues.label_seq_id 1 1 Y 1 A LEU 37 ? A LEU 38 2 1 Y 1 A ASP 38 ? A ASP 39 3 1 Y 1 A THR 39 ? A THR 40 4 1 Y 1 A GLU 40 ? A GLU 41 5 1 Y 1 A THR 41 ? A THR 42 6 1 Y 1 A GLU 42 ? A GLU 43 7 1 Y 1 A GLY 43 ? A GLY 44 8 1 Y 1 A GLY 153 ? A GLY 154 9 1 Y 1 A VAL 154 ? A VAL 155 10 1 Y 1 A PRO 155 ? A PRO 156 11 1 Y 1 A VAL 156 ? A VAL 157 12 1 Y 1 A ARG 157 ? A ARG 158 13 1 Y 1 A THR 158 ? A THR 159 14 1 Y 1 A TYR 159 ? A TYR 160 15 1 Y 1 A THR 160 ? A THR 161 16 1 Y 1 A HIS 161 ? A HIS 162 # loop_ _pdbx_entity_nonpoly.entity_id _pdbx_entity_nonpoly.name _pdbx_entity_nonpoly.comp_id 2 '4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE' FRV 3 water HOH #